{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:02Z","timestamp":1790673182858,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anai.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T05:54:41Z","timestamp":1626760481000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders"],"prefix":"10.1016","volume":"127","author":[{"given":"Javier I.","family":"Mu\u00f1oz-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s C.","family":"Garc\u00eda-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"\u00c1lvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0001","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0002","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0003","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee work group report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.07.014_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2015.07.017","article-title":"Non-IgE mediated mast cell activation","volume":"778","author":"Yu","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol Res"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0006","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2014.06.031","article-title":"Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood","volume":"135","author":"Broesby-Olsen","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2021.07.014_bib0007","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.jaip.2019.05.027","article-title":"Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: a prospective study in 178 patients from 5 tertiary centers in Spain","volume":"7","author":"Gonz\u00e1lez-de-Olano","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2021.07.014_bib0008","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand","volume":"6","author":"Yarden","year":"1987","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.anai.2021.07.014_bib0009","first-page":"2207","article-title":"Organization and nucleotide sequence of the human KIT (mast\/stem cell growth factor receptor) proto-oncogene","volume":"7","author":"Giebel","year":"1992","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0010","first-page":"2224","article-title":"Interspecies molecular chimeras of kit help define the binding site of the stem cell factor","volume":"13","author":"Lev","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0012","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.1460-2075.1988.tb02907.x","article-title":"Primary structure of c-kit: relationship with the CSF-1\/PDGF receptor kinase family\u2013oncogenic activation of v-kit involves deletion of extracellular domain and C terminus","volume":"7","author":"Qiu","year":"1988","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm1399","article-title":"Juxtamembrane autoinhibition in receptor tyrosine kinases","volume":"5","author":"Hubbard","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0014","first-page":"157","article-title":"c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture","volume":"22","author":"Simmons","year":"1994","journal-title":"Exp Hematol"},{"issue":"12","key":"10.1016\/j.anai.2021.07.014_bib0015","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood.V80.12.3009.3009","article-title":"Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells","volume":"80","author":"Irani","year":"1992","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.anai.2021.07.014_bib0016","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2017-12-821413","article-title":"A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice","volume":"131","author":"Dahlin","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-0897.2002.01095.x","article-title":"Molecular genetics of male infertility: stem cell factor\/c-kit system","volume":"48","author":"Grimaldi","year":"2002","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0018","first-page":"965","article-title":"The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others","volume":"142","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"issue":"13","key":"10.1016\/j.anai.2021.07.014_bib0019","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1002\/j.1460-2075.1991.tb04989.x","article-title":"Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis","volume":"10","author":"Blume-Jensen","year":"1991","journal-title":"EMBO J"},{"issue":"24","key":"10.1016\/j.anai.2021.07.014_bib0020","doi-asserted-by":"crossref","first-page":"16965","DOI":"10.1074\/jbc.274.24.16965","article-title":"STAT protein recruitment and activation in c-Kit deletion mutants","volume":"274","author":"Brizzi","year":"1999","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.anai.2021.07.014_bib0021","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1182\/blood.V87.9.3688.bloodjournal8793688","article-title":"JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor","volume":"87","author":"Weiler","year":"1996","journal-title":"Blood"},{"issue":"19-20","key":"10.1016\/j.anai.2021.07.014_bib0022","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","article-title":"Signal transduction via the stem cell factor receptor\/c-Kit","volume":"61","author":"R\u00f6nnstrand","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0023","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/MCB.18.4.2089","article-title":"SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain","volume":"18","author":"Kozlowski","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0024","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2141.2006.06434.x","article-title":"Haematopoietic progenitor cells utilise conventional PKC to suppress PKB\/Akt activity in response to c-Kit stimulation","volume":"136","author":"Edling","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.anai.2019.11.023","article-title":"Mast cell activation syndromes and anaphylaxis: multiple diseases part of the same spectrum","volume":"124","author":"Gonz\u00e1lez-de-Olano","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0091-6749(06)80017-5","article-title":"Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation","volume":"90","author":"Vanderlinden","year":"1992","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0027","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0091-6749(87)80276-2","article-title":"Release of tryptase together with histamine during the immediate cutaneous response to allergen","volume":"80","author":"Schwartz","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.07.014_bib0028","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2016.01.003","article-title":"Mast cell activation disease and the modern epidemic of chronic inflammatory disease","volume":"174","author":"Afrin","year":"2016","journal-title":"Transl Res"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0029","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0030","first-page":"1420","article-title":"Bone marrow mastocytosis: a diagnostic challenge","volume":"10","author":"Zanotti","year":"2021","journal-title":"J Clin Med Res"},{"issue":"12","key":"10.1016\/j.anai.2021.07.014_bib0031","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.3390\/ijms20122976","article-title":"Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches","volume":"20","author":"Valent","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0032","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/cea.12318","article-title":"Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders","volume":"44","author":"Valent","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0033","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"van Anrooij","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0034","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"issue":"6127","key":"10.1016\/j.anai.2021.07.014_bib0035","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.anai.2021.07.014_bib0036","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications","volume":"28","author":"Jara-Acevedo","year":"2015","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.anai.2021.07.014_bib0037","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0038","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"\u00c1lvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0039","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.07.014_bib0040","series-title":"Mast Cell Activation Syndromes Presenting as Anaphylaxis: a Comparison Study Between Two Predictive Scores for Mast Cell Clonality. European Academy of Allergy and Clinical Immunology (Poster);","article-title":"Mast Cell Activation Syndromes Presenting as Anaphylaxis: a Comparison Study Between Two Predictive Scores for Mast Cell Clonality","author":"Rama","year":"2020"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0041","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"10.1016\/j.anai.2021.07.014_bib0042","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anai.2021.07.014_bib0043","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.2018886507","article-title":"Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis","volume":"134","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0044","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0046","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0047","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0048","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2015-07-655100","article-title":"KIT D816V\u2013mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression","volume":"127","author":"Garcia-Montero","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0049","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"\u00c1lvarez-Twose","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2021.07.014_bib0050","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1373\/clinchem.2006.068205","article-title":"Sensitive detection of KIT D816V in patients with mastocytosis","volume":"52","author":"Tan","year":"2006","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0051","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjh.13789","article-title":"Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients","volume":"172","author":"S\u00e1nchez-Mu\u00f1oz","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0052","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0053","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00277-013-1964-1","article-title":"The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis","volume":"93","author":"Erben","year":"2013","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0054","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jcp.2007.047928","article-title":"Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR","volume":"61","author":"Schumacher","year":"2007","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0056","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2017.277897","article-title":"Digital PCR: a sensitive and precise method for KIT D816V quantification in mastocytosis","volume":"64","author":"Greiner","year":"2018","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0057","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ejh.12601","article-title":"Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosis","volume":"96","author":"Kristensen","year":"2016","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0058","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/all.14165","article-title":"Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosis","volume":"75","author":"Kristensen","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2021.07.014_bib0059","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2020-136930","volume":"136","author":"George","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/mp.53.4.188","article-title":"Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia","volume":"53","author":"Sotlar","year":"2000","journal-title":"Mol Pathol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0061","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.13560","article-title":"Concurrent activating KIT mutations in systemic mastocytosis","volume":"173","author":"Lasho","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0062","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0063","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","article-title":"Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0064","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.anai.2021.07.014_bib0065","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0066","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2003.015156","article-title":"A germline mutation in KIT in familial diffuse cutaneous mastocytosis","volume":"41","author":"Tang","year":"2004","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0067","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"F\u00e9ger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0068","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D","article-title":"Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa","volume":"92","author":"Beghini","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0069","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/labinvest.3700524","article-title":"Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation","volume":"87","author":"Nakagomi","year":"2007","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0070","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/leu.2011.354","article-title":"Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor \u03b2 chain and KIT V654A","volume":"26","author":"Spector","year":"2011","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0071","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/pbc.24250","article-title":"Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: detection of the D816A mutation of KIT","volume":"59","author":"Yabe","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0072","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0073","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10322","article-title":"Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations","volume":"73","author":"Pullarkat","year":"2003","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0074","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1525-1578(10)60552-1","article-title":"c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation","volume":"7","author":"Yanagihori","year":"2005","journal-title":"J Mol Diagn"},{"issue":"8","key":"10.1016\/j.anai.2021.07.014_bib0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ajh.21713","article-title":"Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge","volume":"85","author":"Arredondo","year":"2010","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0076","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.iac.2014.01.009","article-title":"Molecular defects in mastocytosis: KIT and beyond KIT","volume":"34","author":"Bibi","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0077","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0609.2012.01761.x","article-title":"Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor","volume":"89","author":"Georgin-Lavialle","year":"2012","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0078","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.anai.2021.07.014_bib0079","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/pde.12381","article-title":"Novel R634W c-kit mutation identified in familial mastocytosis","volume":"32","author":"Pollard","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.anai.2021.07.014_bib0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/jclinpath-2011-200154","article-title":"Mast cell sarcoma of the small intestine: a case report","volume":"64","author":"Bugalia","year":"2011","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0081","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/jid.2012.394","article-title":"A c-kit mutation in exon 18 in familial mastocytosis","volume":"133","author":"W\u00f6hrl","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.07.014_bib0082","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2008-03-147785","article-title":"Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation","volume":"112","author":"Hoffmann","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.anai.2021.07.014_bib0083","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"11-12","key":"10.1016\/j.anai.2021.07.014_bib0084","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"Molderings","year":"2010","journal-title":"Immunogenetics"},{"issue":"12","key":"10.1016\/j.anai.2021.07.014_bib0085","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.anai.2021.07.014_bib0086","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"10","key":"10.1016\/j.anai.2021.07.014_bib0087","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human \u03b1\/\u03b2-tryptase heterotetramers in the pathogenesis of hereditary \u03b1-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.anai.2021.07.014_bib0088","doi-asserted-by":"crossref","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial occurrence of systemic mast cell activation disease","volume":"8","author":"Molderings","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.anai.2021.07.014_bib0089","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.leukres.2014.07.010","article-title":"Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412","volume":"38","author":"de Melo Campos","year":"2014","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"B\u00fcttner","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2021.07.014_bib0091","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/abd1806-4841.20141847","article-title":"Adult mastocytosis: a review of the Santo Ant\u00f3nio Hospital's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease","volume":"89","author":"Fernandes","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"9","key":"10.1016\/j.anai.2021.07.014_bib0092","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1158\/1078-0432.CCR-07-4575","article-title":"Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases","volume":"14","author":"Heinrich","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.anai.2021.07.014_bib0093","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy","volume":"25","author":"Longley","year":"2001","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.anai.2021.07.014_bib0094","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.leukres.2006.02.008","article-title":"Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia","volume":"30","author":"Lorenzo","year":"2006","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.anai.2021.07.014_bib0095","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anai.2021.07.014_bib0096","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)65419-3","article-title":"Activating c-kit gene mutations in human germ cell tumors","volume":"154","author":"Tian","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.anai.2021.07.014_bib0097","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.bmt.1705245","article-title":"A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis","volume":"37","author":"Nakamura","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.anai.2021.07.014_bib0098","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.exphem.2011.05.009","article-title":"Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis","volume":"39","author":"Wasag","year":"2011","journal-title":"Exp Hematol"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:06Z","timestamp":1761053226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621005135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1081120621005135"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.07.014","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}